Ock et al. demonstrated that HMH could inactivate the PI3K/AKT/mammalian target of rapamycin (mTOR) signaling pathway in breast cancer cells, and upregulate the expression of FOXO3a, leading to cell cycle arrest in breast cancer (Ock and Kim, 2021). Here, FOXO3 is linked to breast carcinoma.